Krystal Biotech Inc (KRYS)
Interest coverage
| Dec 31, 2024 | Dec 31, 2023 | Dec 31, 2022 | Dec 31, 2021 | Dec 31, 2020 | ||
|---|---|---|---|---|---|---|
| Earnings before interest and tax (EBIT) | US$ in thousands | 65,695 | 12,897 | -139,975 | -68,078 | -32,167 |
| Interest expense | US$ in thousands | — | 0 | 0 | 1,492 | 0 |
| Interest coverage | — | — | — | -45.63 | — |
December 31, 2024 calculation
Interest coverage = EBIT ÷ Interest expense
= $65,695K ÷ $—K
= —
The interest coverage ratio is a financial metric used to assess a company's ability to meet its interest obligations on outstanding debt. In the case of Krystal Biotech Inc, the interest coverage ratio for the year ending December 31, 2021, is -45.63, indicating that the company's earnings before interest and taxes (EBIT) is less than its interest expenses. A negative interest coverage ratio raises concerns about the company's financial health and ability to service its debt obligations. Additionally, the absence of data for the years 2020, 2022, 2023, and 2024 indicates a lack of available information or potentially further challenges in meeting interest payments. It is essential for investors and stakeholders to closely monitor Krystal Biotech Inc's financial performance and debt management strategy to ensure sustainable operations.
Peer comparison
Dec 31, 2024